Cumberland Pharmaceuticals (CPIX) Reports Q4 EPS of $0.03

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q4 EPS of $0.03, versus $0.10 reported last year. Revenue for the quarter came in at $8.04 million, versus $9.33 million reported last year.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• Academy Sports and Outdoor (ASO) Tops Q2 EPS by 22c, Offers Guidance
• Premarket movers: Meta Jumps on AI agent launch, NETGEAR surges
• J.Jill (JILL) Tops Q2 EPS by 67c, Beats on Revenue; Offers Guidance